EUVIMEDEUVIMED entdecken
Crossref

Heterodimeric prodrug nanoassembly overcomes chemoresistance and ignites immunotherapy in glioblastoma

Guanting Li, Shunzhe Zheng, Penghui Wei, Haonan Li, Meixiu Lu, Xuegang Niu, Jiebo Li, Huimin Wang, Wen Huang, Chenyu Ding, Yuanxiang Lin, Yang Zhu und 1 weitere

Chemical Engineering Journal · 2026-07 · 540 · 176873

DOI: 10.1016/j.cej.2026.176873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-07. Verfasst von Guanting Li und 12 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Fujian Medical University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Fujian Medical University

Zitieren

APA

Li, G., Zheng, S., Wei, P., Li, H., Lu, M., Niu, X., Li, J., Wang, H., Huang, W., Ding, C., Lin, Y., Zhu, Y., & Kang, D. (2026). Heterodimeric prodrug nanoassembly overcomes chemoresistance and ignites immunotherapy in glioblastoma. Chemical Engineering Journal, 540, 176873. https://doi.org/10.1016/j.cej.2026.176873

Vancouver

Li G, Zheng S, Wei P, Li H, Lu M, Niu X, et al. Heterodimeric prodrug nanoassembly overcomes chemoresistance and ignites immunotherapy in glioblastoma. Chemical Engineering Journal. 2026;540:176873. doi:10.1016/j.cej.2026.176873

BibTeX
@article{Li2026,
  author = {Li, Guanting and Zheng, Shunzhe and Wei, Penghui and Li, Haonan and Lu, Meixiu and Niu, Xuegang and Li, Jiebo and Wang, Huimin and Huang, Wen and Ding, Chenyu and Lin, Yuanxiang and Zhu, Yang and Kang, Dezhi},
  title = {Heterodimeric prodrug nanoassembly overcomes chemoresistance and ignites immunotherapy in glioblastoma},
  journal = {Chemical Engineering Journal},
  year = {2026},
  volume = {540},
  pages = {176873},
  doi = {10.1016/j.cej.2026.176873}
}
Kostenlos starten →